The Geras Solutions Cognitive Test for Assessing Cognitive Impairment: Normative Data from a Population-Based Cohort - 21/11/24

Doi : 10.14283/jpad.2023.9 
Victor Bloniecki 1, 12, , J. Ulfvarson 2, K. Javanshiri 3, G. Hagman 4, 5, Y. Freund-Levi 6, 7, 8, A. Nordströmg 9, 10, 11
1 Dermatology and Venereology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden 
2 Department of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, Stockholm, Sweden 
3 Department of Clinical Sciences Lund, Division of Pathology, Lund University, Lund, Sweden 
4 Department of Neurobiology, Caring Sciences and Society (NVS), Division of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institute, Stockholm, Sweden 
5 Theme Aging, Karolinska University Hospital, Stockholm, Sweden 
6 Department of Clinical Science and Education, Södersjukhuset Karolinska Institutet, Stockholm, Sweden 
7 School of Medicine, Örebro University, Örebro, Sweden 
8 Department of Geriatrics, University Hospital Örebro and Södertälje Hospital, Örebro, Sweden 
9 Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden 
10 Department of Health Sciences, The Swedish Winter Sports Research Centre, Mid Sweden University, Östersund, Sweden 
11 School of Sport Sciences, UiT the Arctic University of Norway, Tromsø, Norway 
12 Kocksgatan 5, apartment 1303, 116 24, Stockholm, Sweden 

a Victor.bloniecki.kallio@ki.se Victor.bloniecki.kallio@ki.se

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

There is a need for the development of accurate, accessible and efficient screening instruments, focused on early-stage detection of neurocognitive disorders. The Geras Solutions cognitive test (GSCT) has showed potential as a digital screening tool for cognitive impairment but normative data are needed.

Objective

The aim of this study was to obtain normative data for the GSCT in cognitively healthy patients, investigate the effects of gender and education on test scores as well as examine test-retest reliability.

Methods

The population in this study consisted of 144 cognitively healthy subjects (MMSE>26) all at the age of 70 who were earlier included in the Healthy Aging Initiative Study conducted in Umeå, Sweden. All patients conducted the GSCT and a subset of patients (n=32) completed the test twice in order to establish test-retest reliability.

Results

The mean GSCT score was 46.0 (±4.5) points. High level of education (>12 years) was associated with a high GSCT score (p = 0.02) while gender was not associated with GSCT outcomes (p = 0.5). GSCT displayed a high correlation between test and retest (r(30) = 0.8, p <0.01).

Conclusion

This study provides valuable information regarding normative test-scores on the GSCT for cognitively healthy individuals and indicates education level as the most important predictor of test outcome. Additionally, the GSCT appears to display a good test-retest reliability further strengthening the validity of the test.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Normative data, digital cognitive test, neurocognitive disorder


Mappa


© 2023  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 10 - N° 2

P. 207-211 - Aprile 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • A Large Retrospective Cohort Study on the Risk of Alzheimer’s Disease and Related Dementias in Association with Vascular Diseases and Cancer Therapy in Men with Prostate Cancer
  • Xianglin L. Du, L. Song
| Articolo seguente Articolo seguente
  • Longitudinal Exposure—Response Modeling of Multiple Indicators of Alzheimer’s Disease Progression
  • D.G. Polhamus, Michael J. Dolton, J.A. Rogers, L. Honigberg, J.Y. Jin, A. Quartino, Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.